ClinicalTrials.Veeva

Menu

Serum Free Light Change in Multiple Myeloma

A

Azienda Ospedaliera San Giovanni Battista

Status

Completed

Conditions

Multiple Myeloma

Study type

Observational

Funder types

Other

Identifiers

NCT00910078
sFLC r, KLR and IFIX

Details and patient eligibility

About

The purpose of this study is to evaluate the predictive role of free Kappa/Lambda ration in Multiple Myeloma post-transplant.

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Patients affected with Multiple Myeloma who underwent autologous or auto/allogenic stem cell transplantation.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems